ETON
Eton Pharmaceuticals, Inc. Health Care Pharmaceutical Preparations Russell 3000
$52.18Close
$1.4BMarket cap
$14.35 – $64.4352-week range
Nov 5, 2026Next report · after the close
Highlights
Strengths
- Leading the market RS 99 · stronger than 99% of stocks over 12 months
- Volume drying up last 10 days 31% under the 50-day average
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
19%
1wk
up 4.4%
price change
1mo
up 1.3%
price change
12-month return
up 186%
market up 11% ·
its own up 174%
F-score
4 / 9
Weak
Altman Z
12.25
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
54.0×
price / book
Earnings yield
down 0.1%
EBIT / enterprise value
Cheaper than
17%
of the market · expensive
Revenue growth
up 105%
year on year
EPS growth
—
latest quarter
Sales growth
up 99%
latest quarter · +58 pts
ROE
down 18%
return on equity
Free cash margin
up 13%
$10.2M FCF
D/E
0.83
long-term debt / equity
Net debt / EBITDA
-1.3×
net cash
Interest cover
Lossoperating loss
Piotroski tests
- not yet profitable on its assets
- short-term liquidity weakened
- issued more shares
- gross margin narrowed
- assets working less efficiently
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
Repair signals
- Long-term debt down 27% ($0.0B → $0.0B)
Trade setup
ATR%
4.9%
$2.54 a day · 2×ATR $47.10
RS
99 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.6×
vs 50-day average
Up/down volume
1.02
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Gross margin narrowing Gross margin fell from 60.0% to 53.5%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Aug 13, 2026
Last shock
Sep 30, 2026-13% in one session3.0× volumeon an SEC filing+1% since
Financials
- Gross 53%
- Net -6%
- Free cash 13%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $39,000 | $21.8M | $21.3M | $31.6M | $39.0M | $80.0M |
| Gross margin | -1018% | 87% | 67% | 67% | 60% | 53% |
| Operating income | -$27.1M | -$1.5M | -$8.3M | -$1.2M | -$2.6M | -$844,000 |
| Net income | -$28.0M | -$2.0M | -$9.0M | -$936,000 | -$3.8M | -$4.6M |
| Net margin | -71718% | -9% | -42% | -3% | -10% | -6% |
| Earnings per share | -$1.33 | -$0.08 | -$0.36 | -$0.04 | -$0.15 | -$0.17 |
| Free cash flow | -$22.4M | -$4.7M | $4.8M | $6.8M | $943,000 | $10.2M |
| Free cash margin | -57426% | -22% | 23% | 22% | 2% | 13% |
| Cash | $21.3M | $14.4M | $16.3M | $21.4M | $14.9M | $25.9M |
| Long-term debt | $6.5M | $5.3M | $5.4M | $0 | $29.8M | $21.8M |
| Shareholders' equity | $17.6M | $17.6M | $13.1M | $15.5M | $24.4M | $26.2M |
| Shares outstanding | 24.31m | 24.63m | 25.35m | 25.69m | 26.71m | 27.05m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 13, 2026 | Quarterly ↗ | Jun 30, 2026 | 44d |
| May 14, 2026 | Quarterly ↗ | Mar 31, 2026 | 44d |
| Mar 19, 2026 | Annual ↗ | Dec 31, 2025 | 78d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 13, 2025 | Quarterly ↗ | Mar 31, 2025 | 43d |
| Mar 18, 2025 | Annual ↗ | Dec 31, 2024 | 77d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Mar 14, 2024 | Annual ↗ | Dec 31, 2023 | 74d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 14, 2026 | Material agreement · Acquisition or disposal ↗ |
| Sep 28, 2026 | Other events ↗ |
| Aug 13, 2026 | Results ↗ |
| Aug 5, 2026 | Material agreement · Acquisition or disposal ↗ |
| Aug 4, 2026 | Director or officer change ↗ |
| Jul 29, 2026 | Other events ↗ |
| Jun 9, 2026 | Shareholder vote ↗ |
| May 19, 2026 | Material agreement · Acquisition or disposal ↗ |
| May 14, 2026 | Results ↗ |
| May 1, 2026 | Other events ↗ |
| Apr 27, 2026 | Other events ↗ |
| Apr 16, 2026 | Director or officer change · Regulation FD ↗ |